Glaxosmithkline Pharmaceuticals Ltd : GLAXO

Glaxosmithkline Pharmaceuticals Ltd : GLAXO

SYMBOL:GLAXOLMG Score: *coming soon*
SECTOR: PharmaceuticalsINDUSTRY: Pharmaceuticals – Multinational

GSK India is committed to providing medicines that will improve peoples quality of life and truly make a difference to patients. Their ultimate goal is to leverage the power of science through new innovations in both preventive and curative healthcare and They are a leader in many therapeutic areas where they provide healthcare solutions.(

Glaxosmithkline Pharmaceuticals Ltd Price Chart



News

Glaxosmithkline Pharmaceuticals Ltd Quarter Results

QuarterSep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Dec 18Sep 18
Sales879.32648.59775.8778.59882.02787.97750.81825.35816.31735.65
Expense674.46534.52602.24654.2688.01622.68587.83688.2651.28600.02
Other Income-55.0957.9227.09-737.4417.0230.8172.6445.423.229.73
Depreciation21.9621.7722.5918.3322.719.0613.6812.0411.5111.36
Interest0.881.081.512.980.920.930.080.050.220.2
Profit before tax126.93149.14176.55-634.32587.41176.11221.86170.48156.52133.8
Tax50.4638.3138.4826.8484.6662.5775.0556.8155.6949.72
Net Profit76.47110.83138.07-661.16502.75113.54146.81113.67100.8384.08
Operating Profit204.86114.07173.56124.39194.01165.29162.98137.15165.03135.63

News

Glaxosmithkline Pharmaceuticals Ltd Annual Results

AnnualMar 20Mar 19Mar 18Mar 17Mar 16Mar 15Mar 14Mar 13Mar 12
Sales3224.383128.122871.462908.472837.913304.522562.692646.682414.42151.06
Expense3187.132496.262481.522324.45000000000032662.282679.532137.331717.711724.13000000000031432.77
Other Income286.66151.0972.34121.24139.17149.11204.130.15-176.81105.23
Depreciation82.6848.5937.9927.0824.9525.3519.8817.8420.4117.63
Interest6.340.550.190.250.420.470.330.00.330.62
Profit before tax305.75682.67539.96511.19578.39755.68711.45834.36604.8845.11
Tax212.55237.27189.24174.38202.25279.27229.78272.48176.21284.54
Net Profit93.2445.39350.73336.81376.14476.41481.67561.88428.59560.57

Glaxosmithkline Pharmaceuticals Ltd Balance Sheet

Balance SheetMar 20Mar 19Mar 18Mar 17Mar 16Mar 15Mar 14Mar 13Mar 12
Equity Share Capital169.41169.4184.784.784.784.784.784.784.784.7
Reserves1651.21970.421972.631922.152098.551744.281905.031922.131851.01866.88
Borrowings0.180.580.991.62.373.124.144.594.915.16
Other Liabilities1314.751770.91889.17995.39869.261383.571135.651076.981089.1844.99
Total Liabilities3135.543911.313947.493003.843054.883215.673129.523088.43029.712801.73
Net Block758.08431.63324.59258.05204.04123.08100.0989.4299.15108.95
Capital Work in Progress120.121002.64922.9605.46267.67115.2261.8643.7916.198.72
Investments0.00.060.060.066.040.0610.0654.97112.19117.9
Other Assets2257.342476.982699.942140.272577.132977.312957.512900.222802.182566.16
Total Assets3135.543911.313947.493003.843054.883215.673129.523088.43029.712801.73
Receivables99.8120.49146.96170.8126.57100.3296.39115.985.3147.03
Inventory483.03486.49500.18425.8525.87375.58346.97285.15333.44285.55
Cash & Bank1083.21171.351296.41899.611391.91910.612041.582066.772014.362002.9
No. of Equity Shares1.6941542E81.6941542E88.470771E78.470771E78.470771E78.47077E78.470771E78.470771E78.470771E78.470771E7
New Bonus Shares0.08.4703017E70.00.00.00.00.00.00.00.0
Face value10.010.010.010.010.010.010.010.010.010.0

Glaxosmithkline Pharmaceuticals Ltd Cash Flow

Cash FlowMar 20Mar 19Mar 18Mar 17Mar 16Mar 15Mar 14Mar 13Mar 12
Cash from Operating Activity490.5409.49472.8234.37138.9337.64281.31313.59335.37479.36
Cash from Investing Activity-56.84-153.45-104.19300.64499.02180.01188.98-109.65358.0386.76
Cash from Financing Activity-427.62-358.36-306.63-510.76-638.33-496.99-494.14-440.63-394.81-297.14
Net Cash Flow6.03-102.3361.9724.24-0.4220.66-23.85-236.69298.59268.98

Reviews

There are no reviews yet.

Be the first to review “Glaxosmithkline Pharmaceuticals Ltd : GLAXO”

Your email address will not be published. Required fields are marked *